Setareh Seyedkazemi is CHIEF DEVELOPMENT OFFICER of Adverum Biotechnologies, Inc.. Currently has a direct ownership of 47,674 shares of ADVM, which is worth approximately $314,171. The most recent transaction as insider was on Sep 15, 2023, when has been sold 6,201 shares (Common Stock) at a price of $1.54 per share, resulting in proceeds of $9,549. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.7K
0% 3M change
0% 12M change
Total Value Held $314,171

Setareh Seyedkazemi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 15 2023
SELL
Open market or private sale
$9,549 $1.54 p/Share
6,201 Reduced 11.51%
47,674 Common Stock
Sep 19 2022
SELL
Open market or private sale
$6,482 $1.07 p/Share
6,058 Reduced 11.23%
47,875 Common Stock
Sep 14 2022
BUY
Grant, award, or other acquisition
-
33,333 Added 38.2%
53,933 Common Stock
May 23 2022
BUY
Open market or private purchase
$16,800 $0.84 p/Share
20,000 Added 49.26%
20,600 Common Stock
SS

Setareh Seyedkazemi

CHIEF DEVELOPMENT OFFICER
Redwood City, CA

Track Institutional and Insider Activities on ADVM

Follow Adverum Biotechnologies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADVM shares.

Notify only if

Insider Trading

Get notified when an Adverum Biotechnologies, Inc. insider buys or sells ADVM shares.

Notify only if

News

Receive news related to Adverum Biotechnologies, Inc.

Track Activities on ADVM